Skip to content

The efficacy of acupuncture for the treatment and the fertility improvement in child-bearing period female with Hashimoto Disease: a randomized controlled study

A systematic study on the criteria of syndrome differentiation of kidney Yang deficiency in infertility

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003161
Enrollment
Unknown
Registered
2020-03-27
Start date
2020-04-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hashimoto Disease

Interventions

Sham acupuncture group:Sham acupuncture
Acupuncture group:acupuncture

Sponsors

Chengdu University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: Patients who meet all of the following conditions will be considered for enrollment: 1. Females, aged between 20 and 45 years; 2. Patients with Hashimoto's thyroiditis with normal thyroid function(TSH < 5.0 mIU/L) ; 3. Patients trying to conceive; 4. Patients willing to participate in the study and sign an informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with infertility caused by diseases of reproductive system organs or male infertility; 2. Patients with bleeding disorder (such as thrombocytopenia and coagulation disorder with bleeding tendency); 3. Patients with mental illness (severe anxiety and depression, schizophrenia); 4. Patients with malignant tumors and serious organic diseases; 5. Patients with a history of thyroid radioiodine therapy or surgical intervention; 6. Patients who use immunosuppressants, immunostimulants or drugs (such as corticosteroids, lithium and amiodarone) that interfere with the production, transport and metabolism of thyroid hormones; 7. Patients with pacemaker, metal allergy or artificial joint; 8. Patients who participated in other clinical trials in the past 3 months.

Design outcomes

Primary

MeasureTime frame
TPOAb;

Secondary

MeasureTime frame
TGAb, fT4, fT3, thyroxine, TSH;pregnancy rate(%), pregnancy losses (%), and live birth rate (%);primary ovarian insufficiency (%);AMH, FSH, LH, E2;

Countries

China

Contacts

Public ContactLu Hua

Chengdu University of Traditional Chinese Medicine

1924238034@qq.com+86 13668219665

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026